ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 619102 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 619102; 2) Community: the network communities that were significantly associated with the response to NSC 619102; 3) Molecule: the relationships between components within communities and NSC 619102; 4) MDR: the compounds that were significantly associated with the NSC 619102.

NSC Compound Enrichment Correlation
NSC 144126 Null 0.0396077140933377 0.32107175
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.0396077140933377 0.20759113
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0396077140933377 0.3040009
NSC 303861 L-Cysteine analog 0.0396077140933377 0.46576148
NSC 339137 PHYSALOLACTONE 0.0396077140933377 0.51638842
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0396077140933377 0.055121005
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0396077140933377 0.15298478
NSC 371777 Null 0.0396077140933377 0.29481468
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0396077140933377 0.56903065
NSC 601518 Null 0.0396077140933377 0.65243339
Total:82  Current:70    [First] [Prev] [Next] [Last]